Description
This webinar critically examines the growing claims around consumer and clinical wearables that promise to measure brain function using AI. Through a neuroscience and evidence-based lens, the session will explore what is scientifically feasible today in assessing cerebral physiology, and where current technologies fall short. Experts will discuss established methods of brain monitoring, limitations of non-invasive wearables, and the importance of validation against clinical gold standards. The webinar also addresses regulatory, ethical, and patient-safety considerations in the rapidly evolving neurotech space. Designed for clinicians, researchers, and health-tech professionals, this session aims to separate genuine innovation from hype.
Summary Listen
- A webinar addressed the misuse of brain health technologies, specifically targeting an innovator promoting a device that allegedly measures brain blood flow using a temple-mounted device. The primary concern is the propagation of scientifically inaccurate claims, especially given the existence of established and peer-reviewed technologies like MRI perfusion and CT perfusion, which still have limitations in accurately measuring brain blood flow due to biological complexities.
- The discussion emphasized the importance of understanding brain function, which encompasses electrical activity (EEG signals), neurovascular coupling, cerebral perfusion, and metabolic demands. The speaker highlighted the distinction between peripheral signals (e.g., heart rate) and cerebral physiology, noting that the skull and scalp act as significant barriers, making accurate blood flow measurement through wearables challenging.
- The presenter elaborated on the limitations of common devices such as EEG headbands and functional near-infrared spectroscopy (fNIRS) machines. EEG headbands primarily detect electrical signals from the scalp and are susceptible to artifacts. FNIRS machines, like the Mindy device, measure relative changes in cortical oxygenation rather than absolute cerebral blood flow. Furthermore, insights derived from these devices often rely on pattern recognition through AI and not direct physiological measurements.
- The webinar contrasted wellness and clinical uses of brain monitoring devices. Wellness applications focus on self-awareness and personal insights, whereas clinical applications require high precision and accuracy for diagnosis and decision-making. Trans Cranial Doppler is very effective and requires training to get the readings. The speaker discussed the importance of validation, emphasizing reproducibility, gold standard comparisons, peer review, and regulatory oversight, which is why it's non negotiable.
- The discussion explored the role of AI in this context, emphasizing that it is an amplifier rather than a magical tool. AI is proficient at pattern detection, but it cannot validate biology. Incorrect sensor input or flawed physiological assumptions lead to confident but inaccurate results. The speaker addressed the risk of overclaiming, which could lead to patient anxiety, false assurance, and erosion of trust.
- The presentation concluded with emphasizing the value of transparent, honest claims about limitations and the importance of collaboration between engineers and clinicians in innovation. The take-home message was that technology is not understanding, signals are not physiology, and innovation requires validation, and highlighted key points: tech is not understanding, signals don't equal physiology, and innovation needs validation.
Sample Certificate
About the Speakers
Dr. Bhupesh Kumar Mansukhani
Director and Founder of NeuroMet Wellness Care, Gurugram, Haryana
Comments
Comments
You must be logged in to leave a comment.